Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis.

The National Stock Exchange (NSE) announced on Wednesday, November 13, that it has introduced F&O contracts on 45 new stocks with effect from (w.e.f) Friday, November 29, 2024. According to the NSE ...

Investors who participated in the IPO can consider holding their shares, but should closely monitor the company's performance ...

According to Swiggy’s Draft Red Herring Prospectus, the total number of outstanding ESOPs as of September 2024 amounted to ...

U.S. stocks are drifting near their records after the latest inflation update boosted hopes that more help for the economy ...

Benchmark Indian equity indices BSE Sensex and Nifty 50 opened slightly higher on Thursday, amid mixed global cues.

The S&P 500 and the 30-stock Dow ended Wednesday near the flatline, raising questions about the rally's staying power. Here's ...

U.S. stocks finished mostly higher on Wednesday, with the S&P 500 barely eking out a gain, after October's consumer-price index came in cooler than some market participants had expected. The Dow ...

Inflation accelerated slightly for the month of October, sparking concern the Fed could pause its interest rate-cutting cycle ...

The 2024 election has boosted U.S. stocks to fresh highs, but the same can’t be said for the rest of the world. The S&P 500 was mostly unchanged on Wednesday after jumping nearly 5% since the Monday ...

The Dow Jones Industrial Average and S&P 500 were in the process of having most of Wednesday's earlier gains evaporate during the final hour of trading, as market participants continued to focus on ...

U.S. stocks were higher on Wednesday afternoon as the so-called Trump trade showed no signs of stopping. Stocks viewed as beneficiaries of Donald Trump's return to the White House were leading the ...